Cargando…

COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding

BACKGROUND: Complications under anticoagulant treatment in patients with COVID-19-associated venous thromboembolism (VTE) have not been consistently reported. OBJECTIVES: This study aimed to compare the 90-day rates of VTE recurrences and major bleeding in patients with COVID-19-associated VTE versu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Demelo-Rodriguez, Pablo, Alonso-Beato, Rubén, Jara-Palomares, Luis, Galeano-Valle, Francisco, Bura-Riviere, Alessandra, Visonà, Adriana, Francisco, Iria, Vidal, Gemma, López-Ruiz, Antonio, Monreal, Manuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569976/ https://www.ncbi.nlm.nih.gov/pubmed/37840687 http://dx.doi.org/10.1016/j.rpth.2023.102206

Ejemplares similares

Prediction of Major Bleeding in Anticoagulated Patients for Venous Thromboembolism: Comparison of the RIETE and the VTE-BLEED Scores
por: Lecumberri, Ramón, et al.
Publicado: (2021)

Systematic testing for venous thromboembolism in hospitalized patients with COVID-19 and raised D-dimer levels
por: Weinberg, Ido, et al.
Publicado: (2021)

Omalizumab as a Provoking Factor for Venous Thromboembolism
por: Oblitas, Crhistian-Mario, et al.
Publicado: (2019)

Risk of thrombosis recurrence among patients with COVID-19 and surgery-associated venous thromboembolism
por: Alonso-Beato, R., et al.
Publicado: (2023)

Inflammatory Biomarkers in the Short-Term Prognosis of Venous Thromboembolism: A Narrative Review
por: Galeano-Valle, Francisco, et al.
Publicado: (2021)

Predictors of use of direct oral anticoagulants in patients with venous thromboembolism: Findings from the Registro Informatizado Enfermedad Tromboembólica registry
por: Lorenzo, Alicia, et al.
Publicado: (2022)

Rivaroxaban for the treatment of venous thromboembolism in real life: A single-center prospective study
por: Demelo-Rodríguez, Pablo, et al.
Publicado: (2019)

Venous Thrombosis within 30 Days after Vaccination against SARS-CoV-2 in a Multinational Venous Thromboembolism Registry
por: Bikdeli, Behnood, et al.
Publicado: (2022)

Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism
por: Galeano-Valle, F., et al.
Publicado: (2020)

Sex Differences in Patients Receiving Anticoagulant Therapy for Venous Thromboembolism
por: Blanco-Molina, Angeles, et al.
Publicado: (2014)

Cellular Indices and Outcome in Patients with Acute Venous Thromboembolism
por: Siddiqui, Fakiha, et al.
Publicado: (2022)

Fatal Events in Cancer Patients Receiving Anticoagulant Therapy for Venous Thromboembolism
por: Farge, Dominique, et al.
Publicado: (2015)

Validation of a prognostic score for hidden cancer in unprovoked venous thromboembolism
por: Jara-Palomares, Luis, et al.
Publicado: (2018)

Validation of a Prognostic Score to Identify Hospitalized Patients with COVID-19 at Increased Risk for Bleeding
por: Demelo-Rodriguez, Pablo, et al.
Publicado: (2021)

Platelet Count and Major Bleeding in Patients Receiving Vitamin K Antagonists for Acute Venous Thromboembolism, Findings From Real World Clinical Practice
por: Giorgi-Pierfranceschi, Matteo, et al.
Publicado: (2015)

Platelet Count and Bleeding in Patients Receiving Anticoagulant Therapy for Venous Thromboembolism: Lesson from the RIETE Registry
por: Di Micco, Pierpaolo, et al.
Publicado: (2019)

Analysis of clinical factors affecting the rates of fatal pulmonary embolism and bleeding in cancer patients with venous thromboembolism
por: Trujillo-Santos, Javier, et al.
Publicado: (2017)

D-Dimer Measured at Diagnosis of Venous Thromboembolism is Associated with Risk of Major Bleeding
por: Johnsen, Håkon S., et al.
Publicado: (2019)

Predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolism
por: Wells, Philip S., et al.
Publicado: (2022)

Trajectories of adherence to extended treatment with warfarin and risks of recurrent venous thromboembolism and major bleeding
por: Kang, Hye-Rim, et al.
Publicado: (2023)

Bleeding risk assessment for venous thromboembolism prophylaxis
por: Chindamo, Maria Chiara, et al.
Publicado: (2021)

Different Types of Statins and All-Cause Mortality during Anticoagulation for Venous Thromboembolism: Validation Study from RIETE Registry
por: Siniscalchi, Carmine, et al.
Publicado: (2020)

PICO Questions and DELPHI Methodology for the Management of Venous Thromboembolism Associated with COVID-19
por: Riera-Mestre, Antoni, et al.
Publicado: (2021)

Cancer Histology and Natural History of Patients with Lung Cancer and Venous Thromboembolism
por: Ruiz-Artacho, Pedro, et al.
Publicado: (2022)

Comparison of Four Bleeding Risk Scores to Identify Rivaroxaban‐treated Patients With Venous Thromboembolism at Low Risk for Major Bleeding
por: Kline, Jeffrey A., et al.
Publicado: (2016)

Risk Factors of Unfavorable Outcomes, Major Bleeding, and All-Cause Mortality in Patients with Venous Thromboembolism
por: Lee, Han Young, et al.
Publicado: (2021)

Contrasts in Glioblastoma—Venous Thromboembolism versus Bleeding Risk
por: Muster, Viktoria, et al.
Publicado: (2021)

Biomarkers of bleeding and venous thromboembolism in patients with acute leukemia
por: Hisada, Yohei, et al.
Publicado: (2023)

Prognostic Impact of Active Cigarette Smoking on Mortality in Patients with Acute Venous Thromboembolic Events, Findings from Real World Data
por: Giorgi-Pierfranceschi, Matteo, et al.
Publicado: (2022)

Could venous thromboembolism and major bleeding be indicators of lung cancer mortality? A nationwide database study
por: Howlett, Jennifer, et al.
Publicado: (2020)

Biomarker derived risk scores predict venous thromboembolism and major bleeding among patients with COVID‐19
por: Woller, Scott C., et al.
Publicado: (2022)

Using machine learning to predict venous thromboembolism and major bleeding events following total joint arthroplasty
por: Shohat, Noam, et al.
Publicado: (2023)

COVID-19 as a trigger for splenic infarction in a patient with sickle cell trait: A case report
por: Alejandre-de-Oña, Álvaro, et al.
Publicado: (2021)

Multidisciplinary Care for the Prevention and Treatment of Venous Thromboembolism in Patients with Cancer-Associated Thrombosis (CAT): Impact of Educational Interventions on CAT-Related Events and on Patients’ and Clinicians’ Awareness
por: Zalunardo, Beniamino, et al.
Publicado: (2022)

Risk assessment of venous thromboembolism and bleeding in COVID‐19 patients
por: Wang, Lan, et al.
Publicado: (2022)

Bleeding outcomes in thrombocytopenic acute leukemic patients with venous thromboembolism
por: Wilson, Nathaniel R., et al.
Publicado: (2020)

Evaluation of the predictive value of the bleeding prediction score VTE‐BLEED for recurrent venous thromboembolism
por: Klok, Frederikus A., et al.
Publicado: (2019)

Impact of oral anticoagulant choice for the secondary prevention of venous thromboembolism on the risk of inpatient bleeding
por: MacLehose, Richard F., et al.
Publicado: (2021)

Comparison of long-term complications in cancer patients with incidental and acute symptomatic venous thromboembolism
por: Barca-Hernando, María, et al.
Publicado: (2023)

Clinical Characteristics and Outcomes of Patients with Lung Cancer and Venous Thromboembolism
por: Ruiz-Artacho, Pedro, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gu418idibrn9ser6q8tc0td4du